Skip to main content
Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I - IV clinical trial studies, clinical investigations at all stages of development and therapeutics.

The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.

Publisher: Bentham Science Publishers

More about this publication?
Volume 6, Number 2, 2011

Articles

Treatment Options for Cystic Fibrosis: State of the Art and Future Perspectives
pp. 94-107(14)
Authors: H. Sears, Edmund; J. Gartman, Eric; P. Casserly, Brian

Favourites:
ADD

The Role of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Cardiovascular Disease
pp. 108-113(6)
Authors: Ikonomidis, Ignatios; A. Michalakeas, Christos; Lekakis, John; Parissis, John; Anastasiou-Nana, Maria

Favourites:
ADD

Recent Clinical Evidence for the Treatment of Osteoarthritis: What we have Learned
pp. 114-126(13)
Authors: Sofat, Nidhi; Beith, Iain; G. Anilkumar, P.; Mitchell, Philip

Favourites:
ADD

Melanoma: The Radiotherapeutic Point of View; Review of the Current Literature
pp. 127-133(7)
Authors: A., Zygogianni; G., Kyrgias; J., Kouvaris; K., Mystakidou; H., Gogas; V., Kouloulias

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Design and Endpoints of Clinical and Translational Trials in Advanced Colorectal Cancer. A Proposal from GROUP Español Multidisciplinar en Cancer Digestivo (GEMCAD)
pp. 158-170(13)
Authors: Carrera, Gemma; Garcia-Albeniz, Xabier; Ramon Ayuso, Juan; Aparicio, Jorge; Castells, Antoni; Codony-Servat, Jordi; Feliu, Jaime; Fuster, David; Gallego, Rosa; Pages, Mario; Torres, Ferran; Maurel, Joan

Favourites:
ADD
Favourites:
ADD

Tolvaptan: A New Therapeutic Agent
pp. 177-188(12)
Authors: Aperis, Georgios; Alivanis, Polichronis

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content